{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:42:00Z","timestamp":1778924520596,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2320-B-037-025-"],"award-info":[{"award-number":["MOST 107-2320-B-037-025-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH106- 6M63"],"award-info":[{"award-number":["KMUH106- 6M63"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,3,12]]},"DOI":"10.1038\/s41388-019-1152-4","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T12:02:56Z","timestamp":1578398576000},"page":"2377-2390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing \u03b2-catenin activity"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-5966","authenticated-orcid":false,"given":"Chao-Ju","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Jen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheau-Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2716-0050","authenticated-orcid":false,"given":"Yu-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"1152_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1152_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"1152_CR3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1056\/NEJMra1703413","volume":"377","author":"M Reck","year":"2017","unstructured":"Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377:849\u201361.","journal-title":"N Engl J Med"},{"key":"1152_CR4","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378:2078\u201392.","journal-title":"N Engl J Med"},{"key":"1152_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1591-4","volume":"10","author":"DM Wu","year":"2019","unstructured":"Wu DM, Zhang T, Liu YB, Deng SH, Han R, Liu T, et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K\/AKT signaling. Cell Death Dis. 2019;10:349.","journal-title":"Cell Death Dis"},{"key":"1152_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12015-019-09887-2","volume":"15","author":"AK Yadav","year":"2019","unstructured":"Yadav AK, Desai NS. Cancer stem cells: acquisition, characteristics, therapeutic implications, targeting strategies and future prospects. Stem Cell Rev Rep. 2019;15:331\u201355.","journal-title":"Stem Cell Rev Rep"},{"key":"1152_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bcp.2018.12.010","volume":"160","author":"WS Heng","year":"2019","unstructured":"Heng WS, Gosens R, Kruyt FAE. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting. Biochem Pharmacol. 2019;160:121\u201333.","journal-title":"Biochem Pharmacol."},{"key":"1152_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell."},{"key":"1152_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","volume":"24","author":"PB Gupta","year":"2019","unstructured":"Gupta PB, Pastushenko I, Skibinski A, Blanpain C, Kuperwasser C. Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance. Cell Stem Cell. 2019;24:65\u201378.","journal-title":"Cell Stem Cell"},{"key":"1152_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-319-24932-2_3","volume":"890","author":"V Mittal","year":"2016","unstructured":"Mittal V. Epithelial mesenchymal transition in aggressive lung cancers. Adv Exp Med Biol. 2016;890:37\u201356.","journal-title":"Adv Exp Med Biol"},{"key":"1152_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2016.06.043","volume":"16","author":"TN Beck","year":"2016","unstructured":"Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, et al. Anti-Mullerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer. Cell Rep. 2016;16:657\u201371.","journal-title":"Cell Rep."},{"key":"1152_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17:500\u20133.","journal-title":"Nat Med."},{"key":"1152_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","volume":"22","author":"OH Ocana","year":"2012","unstructured":"Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012;22:709\u201324.","journal-title":"Cancer Cell."},{"key":"1152_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339:580\u20134.","journal-title":"Science."},{"key":"1152_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","volume":"28","author":"M Luo","year":"2018","unstructured":"Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, et al. Targeting breast cancer stem cell state equilibrium through modulation of redox signaling. Cell Metab. 2018;28:69\u201386.e6.","journal-title":"Cell Metab."},{"key":"1152_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1125-0","volume":"21","author":"GV Vijay","year":"2019","unstructured":"Vijay GV, Zhao N, Den Hollander P, Toneff MJ, Joseph R, Pietila M, et al. GSK3beta regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer. Breast Cancer Res. 2019;21:37.","journal-title":"Breast Cancer Res"},{"key":"1152_CR17","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1158\/0008-5472.CAN-14-3265","volume":"75","author":"YW Chang","year":"2015","unstructured":"Chang YW, Su YJ, Hsiao M, Wei KC, Lin WH, Liang CL, et al. Diverse targets of beta-catenin during the epithelial-mesenchymal transition define cancer stem cells and predict disease relapse. Cancer Res. 2015;75:3398\u2013410.","journal-title":"Cancer Res."},{"key":"1152_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/BC.2009.028","volume":"390","author":"C Song","year":"2009","unstructured":"Song C, Lu R, Bienzle D, Liu HC, Yoo D. Interaction of the porcine reproductive and respiratory syndrome virus nucleocapsid protein with the inhibitor of MyoD family-a domain-containing protein. Biol Chem. 2009;390:215\u201323.","journal-title":"Biol Chem"},{"key":"1152_CR19","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362\u20138.","journal-title":"Nucleic Acids Res"},{"key":"1152_CR20","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"1152_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09929-0","volume":"7","author":"V Tiran","year":"2017","unstructured":"Tiran V, Lindenmann J, Brcic L, Heitzer E, Stanzer S, Tabrizi-Wizsy NG, et al. Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition. Sci Rep. 2017;7:10040.","journal-title":"Sci Rep."},{"key":"1152_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cllc.2016.05.015","volume":"17","author":"M Pore","year":"2016","unstructured":"Pore M, Meijer C, de Bock GH, Boersma-van EkW, Terstappen LW, Groen HJ, et al. Cancer stem cells, epithelial to mesenchymal markers, and circulating tumor cells in small cell lung cancer. Clin Lung Cancer. 2016;17:535\u201342.","journal-title":"Clin Lung Cancer"},{"key":"1152_CR23","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","volume":"70","author":"JP Sullivan","year":"2010","unstructured":"Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010;70:9937\u201348.","journal-title":"Cancer Res."},{"key":"1152_CR24","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1074\/jbc.RA118.001689","volume":"293","author":"X Huang","year":"2018","unstructured":"Huang X, Zhu H, Gao Z, Li J, Zhuang J, Dong Y, et al. Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. J Biol Chem. 2018;293:6693\u2013706.","journal-title":"J Biol Chem"},{"key":"1152_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.23756","volume":"14","author":"G Li","year":"2018","unstructured":"Li G, Su Q, Liu H, Wang D, Zhang W, Lu Z, et al. Frizzled7 promotes epithelial-to-mesenchymal transition and stemness via activating canonical Wnt\/beta-catenin pathway in gastric cancer. Int J Biol Sci. 2018;14:280\u201393.","journal-title":"Int J Biol Sci"},{"key":"1152_CR26","doi-asserted-by":"publisher","first-page":"101042831769431","DOI":"10.1177\/1010428317694310","volume":"39","author":"JS Yakisich","year":"2017","unstructured":"Yakisich JS, Azad N, Kaushik V, O\u2019Doherty GA, Iyer AK. Nigericin decreases the viability of multidrug-resistant cancer cells and lung tumorspheres and potentiates the effects of cardiac glycosides. Tumour Biol. 2017;39:1010428317694310.","journal-title":"Tumour Biol."},{"key":"1152_CR27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, et al. Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell. 2002;108:837\u201347.","journal-title":"Cell."},{"key":"1152_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X. Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9\u201326.","journal-title":"Dev Cell"},{"key":"1152_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0092-8674(00)80148-8","volume":"86","author":"CM Chen","year":"1996","unstructured":"Chen CM, Kraut N, Groudine M, Weintraub H. I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell. 1996;86:731\u201341.","journal-title":"Cell."},{"key":"1152_CR30","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1074\/jbc.275.7.4848","volume":"275","author":"S Thebault","year":"2000","unstructured":"Thebault S, Gachon F, Lemasson I, Devaux C, Mesnard JM. Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expression. J Biol Chem. 2000;275:4848\u201357.","journal-title":"J Biol Chem"},{"key":"1152_CR31","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1074\/jbc.M116.758888","volume":"292","author":"RH Oakley","year":"2017","unstructured":"Oakley RH, Busillo JM, Cidlowski JA. Cross-talk between the glucocorticoid receptor and MyoD family inhibitor domain-containing protein provides a new mechanism for generating tissue-specific responses to glucocorticoids. J Biol Chem. 2017;292:5825\u201344.","journal-title":"J Biol Chem"},{"key":"1152_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jmb.2007.01.020","volume":"367","author":"Q Wang","year":"2007","unstructured":"Wang Q, Young TM, Mathews MB, Pe\u2019ery T. Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription. J Mol Biol. 2007;367:630\u201346.","journal-title":"J Mol Biol"},{"key":"1152_CR33","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1128\/MCB.22.18.6393-6405.2002","volume":"22","author":"S Kusano","year":"2002","unstructured":"Kusano S, Raab-Traub N. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol Cell Biol. 2002;22:6393\u2013405.","journal-title":"Mol Cell Biol"},{"key":"1152_CR34","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1128\/MCB.21.5.1866-1873.2001","volume":"21","author":"L Snider","year":"2001","unstructured":"Snider L, Thirlwell H, Miller JR, Moon RT, Groudine M, Tapscott SJ. Inhibition of Tcf3 binding by I-mfa domain proteins. Mol Cell Biol. 2001;21:1866\u201373.","journal-title":"Mol Cell Biol"},{"key":"1152_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s000180050449","volume":"56","author":"A Novak","year":"1999","unstructured":"Novak A, Dedhar S. Signaling through beta-catenin and Lef\/Tcf. Cell Mol Life Sci. 1999;56:523\u201337.","journal-title":"Cell Mol Life Sci"},{"key":"1152_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1389203013381143","volume":"2","author":"S Thebault","year":"2001","unstructured":"Thebault S, Mesnard JM. How the sequestration of a protein interferes with its mechanism of action: example of a new family of proteins characterized by a particular cysteine-rich carboxy-terminal domain involved in gene expression regulation. Curr Protein Pept Sci. 2001;2:155\u201367.","journal-title":"Curr Protein Pept Sci"},{"key":"1152_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.18632\/oncoscience.46","volume":"1","author":"KL Thu","year":"2014","unstructured":"Thu KL, Becker-Santos DD, Radulovich N, Pikor LA, Lam WL, Tsao MS. SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types. Oncoscience 2014;1:326\u201335.","journal-title":"Oncoscience"},{"key":"1152_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcdb.2016.07.028","volume":"63","author":"YR Xu","year":"2017","unstructured":"Xu YR, Yang WX. SOX-mediated molecular crosstalk during the progression of tumorigenesis. Semin Cell Dev Biol. 2017;63:23\u201334.","journal-title":"Semin Cell Dev Biol"},{"key":"1152_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1566524019666190405121139","volume":"19","author":"M Zhang","year":"2019","unstructured":"Zhang M, Wang J, Gao T, Chen X, Xu Y, Yu X, et al. Inhibition of SOX15 sensitizes esophageal squamous carcinoma cells to paclitaxel. Curr Mol Med. 2019;19:349\u201356.","journal-title":"Curr Mol Med"},{"key":"1152_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1152_CR41","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.21873\/anticanres.11510","volume":"37","author":"N Tsoukalas","year":"2017","unstructured":"Tsoukalas N, Aravantinou-Fatorou E, Tolia M, Giaginis C, Galanopoulos M, Kiakou M, et al. Epithelial-mesenchymal transition in non small-cell lung cancer. Anticancer Res. 2017;37:1773\u20138.","journal-title":"Anticancer Res"},{"key":"1152_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/CBM-170835","volume":"22","author":"D Wang","year":"2018","unstructured":"Wang D, Wen GM, Hou W, Xia P. The roles of CD133 expression in the patients with non-small cell lung cancer. Cancer Biomark. 2018;22:385\u201394.","journal-title":"Cancer Biomark."},{"key":"1152_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/JTO.0b013e31816de2b8","volume":"3","author":"JP Sculier","year":"2008","unstructured":"Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P, International Staging C, et al. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th edition. J Thorac Oncol. 2008;3:457\u201366.","journal-title":"J Thorac Oncol"},{"key":"1152_CR44","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/0008-5472.CAN-12-1733","volume":"73","author":"YP Liu","year":"2013","unstructured":"Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, et al. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Cancer Res. 2013;73:406\u201316.","journal-title":"Cancer Res."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1152-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T13:02:42Z","timestamp":1650200562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1152-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,3,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-1152-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}